Investigating the role of SNAI1 and ZEB1 expression in prostate cancer progression and immune modulation of the tumor microenvironment (2024)
- Authors:
- USP affiliated authors: REIS, RODOLFO BORGES DOS - FMRP ; SQUIRE, JEREMY ANDREW - FMRP ; SAGGIORO, FABIANO PINTO - FMRP ; ARCHANGELO, LETICIA FRÖHLICH - FMRP ; AVANTE, FILIPE STRIPARI - FMRP
- Unidade: FMRP
- DOI: 10.3390/cancers16081480
- Subjects: BIOMARCADORES; IMUNOLOGIA; IMUNOTERAPIA; MATRIZ EXTRACELULAR; COLÁGENO; PROTEÍNAS; CITOMETRIA DE FLUXO
- Keywords: Biomarkers; Immune evasion; Bioinformatics; Gene signatures; Immunotherapy; Extracellular matrix; Transcriptomics; Collagens; Immune checkpoint proteins; Digital flow cytometry
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LAUTERT-DUTRA, William et al. Investigating the role of SNAI1 and ZEB1 expression in prostate cancer progression and immune modulation of the tumor microenvironment. Cancers, v. 16, n. 8, 2024Tradução . . Disponível em: https://doi.org/10.3390/cancers16081480. Acesso em: 17 fev. 2026. -
APA
Lautert-Dutra, W., Melo, C. M., Chaves, L. P., Sousa, F. C., Crozier, C., Dion, D., et al. (2024). Investigating the role of SNAI1 and ZEB1 expression in prostate cancer progression and immune modulation of the tumor microenvironment. Cancers, 16( 8). doi:10.3390/cancers16081480 -
NLM
Lautert-Dutra W, Melo CM, Chaves LP, Sousa FC, Crozier C, Dion D, Avante FS, Saggioro FP, Reis RB dos, Archangelo LF, Bayani J, Squire JA. Investigating the role of SNAI1 and ZEB1 expression in prostate cancer progression and immune modulation of the tumor microenvironment [Internet]. Cancers. 2024 ; 16( 8):[citado 2026 fev. 17 ] Available from: https://doi.org/10.3390/cancers16081480 -
Vancouver
Lautert-Dutra W, Melo CM, Chaves LP, Sousa FC, Crozier C, Dion D, Avante FS, Saggioro FP, Reis RB dos, Archangelo LF, Bayani J, Squire JA. Investigating the role of SNAI1 and ZEB1 expression in prostate cancer progression and immune modulation of the tumor microenvironment [Internet]. Cancers. 2024 ; 16( 8):[citado 2026 fev. 17 ] Available from: https://doi.org/10.3390/cancers16081480 - Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment
- Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
- PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer
- Quantitative measurement of PTEN loss improves risk assessment in prostate cancer
- Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)
- Análise do impacto da avaliação pré-anestésica em cirurgias uro-oncológicas
- Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics
- Emerging role of PTEN loss in evasion of the immune response to tumours
- Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer
- PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells
Informações sobre o DOI: 10.3390/cancers16081480 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003249183.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
